This slump shouldn’t be too much of a surprise to investors, as the Medical Products company has seen 2 negative revisions in the past few weeks and its current year loss consensus has moved lower over the last 30 days. This suggests there may be more trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent slump will continue, as the earnings picture definitely suggests that this might be the case.
NSTG currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Some better-ranked stocks in the Medical Products industry include Cardica Inc. (CRDC), ICU Medical, Inc. (ICUI) and Eagle Pharmaceuticals Inc. (EGRX). All these stocks carry a Zacks rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
NANOSTRING TECH INC (NSTG): Free Stock Analysis Report
EAGLE PHARMACEUTICALS INC (EGRX): Free Stock Analysis Report
ICU MEDICAL INC (ICUI): Free Stock Analysis Report
CARDICA INC (CRDC): Free Stock Analysis Report
Zacks Investment Research
- Finance Trading
- Personal Investing Ideas & Strategies